Related Experiment Video
Updated: Jun 7, 2026

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
Published on: June 9, 2020
Convergence of Rad6/Rad18 and Fanconi anemia tumor suppressor pathways upon DNA damage
Hwan Ki Park1, Hong Wang, Jun Zhang
1The Hormel Institute, University of Minnesota, Austin, Minnesota, United States of America.
Abstract:
Extremely high cancer incidence associated with patients with Fanconi anemia (FA) suggests the importance of the FA signaling pathway in the suppression of non-FA human tumor development. Indeed, we found that an impaired FA signaling pathway substantially contributes to the development of non-FA human tumors. However, the mechanisms underlying the function of the FA pathway remain less understood. Using RNA interfering approach in combining with cell proliferation and reporter assays, we showed that the function of FA signaling pathway is at least partly mediated through coupling with hRad6/hRad18 signaling (HHR6 pathway). We previously reported that FANCD2 monoubiquitination, a hallmark of the FA pathway activation, can be regulated by HHR6. Here we found that hRad18 can also regulate activation of the FA pathway. More importantly, we found that FANCD2 is capable of modulating activity of DNA translesion synthesis polymerase eta, an effector of HHR6 pathway. These results provide novel insights into how the FA pathway is intertwined with HHR6 pathway to maintain chromosomal stability and suppress the development of human cancer, representing an important conceptual advance in the field of FA cancer research.
Insights
Fanconi anemia (FA) pathway dysfunction contributes to cancer. This study reveals FA pathway interactions with hRad6/hRad18 (HHR6) signaling, uncovering new mechanisms in cancer suppression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Fanconi anemia (FA) patients exhibit high cancer incidence, implicating the FA pathway in tumor suppression.
- Impaired FA signaling is a significant factor in non-FA human tumor development.
- Mechanisms of FA pathway function in cancer suppression are not fully understood.
Purpose of the Study:
- To elucidate the mechanisms by which the FA pathway suppresses non-FA human tumor development.
- To investigate the interplay between the FA pathway and hRad6/hRad18 (HHR6) signaling.
- To identify novel regulatory interactions between FA and HHR6 pathway components.
Main Methods:
- RNA interference (RNAi) techniques were employed to modulate gene function.
- Cell proliferation assays were utilized to assess cellular growth and viability.
- Reporter assays were performed to measure pathway activation.
- FANCD2 monoubiquitination status was analyzed as a marker for FA pathway activation.
Main Results:
- The FA pathway's tumor-suppressive function is partly mediated by its coupling with the HHR6 pathway.
- hRad18 was identified as a regulator of FA pathway activation.
- FANCD2 directly modulates the activity of DNA translesion synthesis polymerase eta, a key HHR6 effector.
- FANCD2 monoubiquitination, a hallmark of FA pathway activation, is influenced by HHR6 signaling.
Conclusions:
- The FA and HHR6 pathways are intricately intertwined to maintain chromosomal stability.
- These interactions provide novel insights into the suppression of human cancer development.
- This research represents a significant conceptual advancement in Fanconi anemia and cancer research.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

